APA (7th ed.) Citation

FF, H., AA, A. E., SH, A., AM, S., A, A., HS, A., . . . M, A. (2026). Ferroptosis-Driven Anticancer Activity of 1,3,4-Oxadiazole-Benzimidazole/Acetamide Hybrids: Design, Synthesis, and Biological Profiling. Archiv der Pharmazie, 359(3), e70229. https://doi.org/10.1002/ardp.70229

Chicago Style (17th ed.) Citation

FF, Hagar, Abd El-Hafeez AA, Abbas SH, Sayed AM, Abdelfattah A, Abd-Ellah HS, Abdelhamid D, and Abdel-Aziz M. "Ferroptosis-Driven Anticancer Activity of 1,3,4-Oxadiazole-Benzimidazole/Acetamide Hybrids: Design, Synthesis, and Biological Profiling." Archiv Der Pharmazie 359, no. 3 (2026): e70229. https://doi.org/10.1002/ardp.70229.

MLA (9th ed.) Citation

FF, Hagar, et al. "Ferroptosis-Driven Anticancer Activity of 1,3,4-Oxadiazole-Benzimidazole/Acetamide Hybrids: Design, Synthesis, and Biological Profiling." Archiv Der Pharmazie, vol. 359, no. 3, 2026, p. e70229, https://doi.org/10.1002/ardp.70229.